Hemothorax Pain Management Guidelines

Foundational Systemic Analgesia

The American College of Physicians recommends paracetamol as the foundational analgesic, providing baseline pain control without respiratory depression risk, and should be started immediately and continued every 6 hours 1, 2, 3.
The American Society of Anesthesiologists suggests NSAIDs or COX-2-specific inhibitors should be initiated early and continued as a short course to improve pain control and enhance recovery, with critical contraindications including renal impairment, heart failure, and active bleeding risk 1, 3, 4.

The National Comprehensive Cancer Network recommends morphine as the standard preferred starting opioid for opioid-naïve patients requiring rescue analgesia, with an initial oral dose of 5-15 mg of short-acting morphine sulfate every 4 hours as needed 5, 6.
Opioids should be reserved exclusively as rescue analgesics for breakthrough pain, not as primary analgesics in the multimodal regimen, to minimize respiratory depression risk 1, 2, 4.

The American Society of Regional Anesthesia and Pain Medicine recommends paravertebral block as the primary regional technique due to superior efficacy and fewer side effects compared to thoracic epidural, with erector spinae plane (ESP) block as a first-choice alternative 1, 2.
Intercostal nerve blocks with local anesthetic plus perineural dexamethasone or dexmedetomidine significantly prolong analgesia duration compared to plain local anesthetic alone 3, 7.

Inadequate pain control directly impairs pulmonary function and causes splinting, atelectasis, and impaired respiratory physiotherapy, making aggressive multimodal analgesia essential for preventing respiratory complications 1, 3.
The Society of Critical Care Medicine suggests that patients with compromised pulmonary function from hemothorax require careful balancing of analgesic adequacy against the need for controlled mobilization 1, 3.

The American Academy of Pain Medicine advises against relying on opioids as primary analgesics, as this increases respiratory depression risk in patients who may already have compromised pulmonary function from hemothorax 1, 2, 4.
The American College of Chest Physicians recommends screening for contraindications before prescribing NSAIDs, including renal impairment, heart failure, and bleeding risk 1, 3.